Publication: Clinical evidence of interventions assessed in Friedreich ataxia: A systematic review
This systematic literature review, published in Therapeutic Advances in Rare Disease, discusses the therapeutic landscape in Friedreich’s ataxia. The review also identifies a considerable unmet need for patients with Friedreich’s ataxia.
Discover the management approach for this rare progressive neurodegenerative genetic condition
Review the published evidence and the current treatment landscape for Friedreich’s ataxia
Explore why further research into effective treatments that slow or reverse the damage in patients is important
Learn more about the unmet treatment need in Friedreich’s ataxia
Jain P, et al. Ther Adv Rare Dis. 2022;3:1–23
Once registered, you will be able to view the abstract and be provided with the DOI links for this publication.
Register now to unlock the content
Register now to access the content on this page
Already registered?
If not, register below
US-FA-0206 | August 2023
Sign in or register to access exclusive content on this site
Register here to access the content on the site US-CORP-0330 | July 2022
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.